Top 10 Companies in the Global Tablet and Pellet Coating Market (2026): Market Leaders Powering Pharmaceutical Innovation

MARKET INSIGHTS

The Global Tablet and Pellet Coating market size was valued at USD 1.92 billion in 2024. The market is projected to grow from USD 2.06 billion in 2025 to USD 3.26 billion by 2032, exhibiting a CAGR of 6.8% during the forecast period.

Tablet and pellet coating is a critical pharmaceutical manufacturing process that applies a thin, uniform layer of coating material to solid oral dosage forms. This functional process is designed to mask unpleasant taste and odor, improve product stability by protecting the active ingredient from light and moisture, facilitate easier swallowing, and provide controlled drug release profiles. The primary coating types include sugar coating and the more modern, efficient film coating, which utilizes polymers like hydroxypropyl methylcellulose (HPMC).

The market growth is primarily driven by the robust expansion of the global pharmaceutical industry and increasing demand for functional coatings that enable modified drug release. However, the market faces challenges from stringent regulatory requirements for approval and the high cost associated with advanced coating technologies. Furthermore, key industry players are actively contributing to market expansion through strategic initiatives and product innovations. For instance, in 2024, BASF SE expanded its production capacity for pharmaceutical polymers in the United States to meet the rising demand for advanced excipients. Other leading companies with significant market presence include Ashland, Dupont Nutrition & Biosciences, and Evonik Industries.

Global Tablet and Pellet Coating Market – View in Detailed Research Report

Top 10 Companies in the Global Tablet and Pellet Coating Market

1. Ashland (USA)

   Headquarters: Parsippany, New Jersey, USA
   Key Offering: Sugar and film coating solutions, polymer blends, and specialty excipients for tablet and pellet applications

   Ashland’s portfolio supports a wide range of dosage forms, from conventional tablets to advanced multiparticulate systems. The company’s investment in high‑speed coating lines and continuous processing technologies has enabled rapid scale‑up and consistent product quality across global customers.

   Sustainability & Growth Initiatives: Expansion of water‑based coating formulations, partnership with research institutions to develop bio‑based polymers, and deployment of digital process controls to reduce waste.

   • Investment in automated coating equipment for high‑volume production
   • Collaboration with pharma developers on controlled‑release formulations
   • Launch of eco‑friendly, solvent‑free coating lines

2. BASF (Germany)

   Headquarters: Ludwigshafen, Germany
   Key Offering: Advanced polymers for film coating, hot‑melt excipients, and specialty additives for taste masking

   BASF’s extensive research and development pipeline delivers high‑performance coating materials that meet stringent regulatory expectations. The company’s recent capacity expansion in the United States underscores its commitment to serving the North American market.

   Sustainability & Growth Initiatives: Development of renewable polymer blends, implementation of energy‑efficient coating processes, and active participation in industry sustainability forums.

   • Expansion of HPMC production capacity
   • Partnerships with major pharma to co‑develop tailored coatings
   • Investment in continuous coating technologies

3. Evonik Industries (Germany)

   Headquarters: Essen, Germany
   Key Offering: Specialty polymers for high‑potency drug formulations, bio‑based coatings, and functional additives for controlled release

   Evonik’s focus on high‑potency and specialty products positions it as a preferred supplier for complex dosage forms. The company’s innovation strategy emphasizes sustainable materials and process efficiency.

   Sustainability & Growth Initiatives: Development of bio‑derived polymers, reduction of solvent usage, and integration of digital monitoring for process optimization.

   • Launch of bio‑based film coating line
   • Collaboration with pharma on modified‑release platforms
   • Investment in AI‑driven quality control

4. DuPont Nutrition & Biosciences (USA)

   Headquarters: Wilmington, Delaware, USA
   Key Offering: Advanced excipients, polymer blends for film coating, and specialty additives for taste masking

   DuPont’s extensive portfolio supports a broad spectrum of dosage forms, and its research collaborations drive the development of next‑generation coating materials.

   Sustainability & Growth Initiatives: Focus on renewable feedstocks, reduction of CO₂ emissions in manufacturing, and digital process integration.

   • Expansion of polymer production capacity in the United States
   • Partnerships with contract manufacturers for continuous coating lines
   • Implementation of real‑time analytics for batch consistency

5. Roquette (France)

   Headquarters: Loos, France
   Key Offering: Plant‑derived excipients, bio‑based film coatings, and functional additives for tablet and pellet coating

   Roquette’s expertise in natural polymers has positioned it as a leader in green‑pharma initiatives, offering coatings that meet sustainability demands while maintaining performance.

   Sustainability & Growth Initiatives: Development of plant‑based polymer blends, partnership with academic institutions for bio‑material research, and adoption of low‑energy coating processes.

   • Launch of bio‑based HPMC alternative
   • Collaboration with pharma for eco‑friendly coating solutions
   • Investment in water‑based coating lines

6. Lubrizol (USA)

   Headquarters: Deerfield, Illinois, USA
   Key Offering: Functional additives for pellet coating, flow‑enhancing agents, and compression aids

   Lubrizol’s product portfolio enhances pellet performance, supporting high‑value therapeutic applications.

   Sustainability & Growth Initiatives: Development of biodegradable additives, integration of process analytics, and partnership with contract manufacturers.

   • Launch of biodegradable flow enhancer
   • Collaboration with CDMOs on pellet coating solutions
   • Implementation of continuous coating technologies

7. Croda International (UK)

   Headquarters: Loughborough, United Kingdom
   Key Offering: Specialty excipients, functional additives for tablet and pellet coating, and process aids

   Croda’s focus on specialty polymers supports the development of advanced drug delivery systems.

   Sustainability & Growth Initiatives: Development of renewable polymer blends, digital process integration, and partnerships with pharma for tailored coatings.

   • Launch of renewable polymer blend for film coating
   • Collaboration with pharma on controlled‑release platforms
   • Investment in AI‑driven process control

8. FujiFilm (Japan)

   Headquarters: Tokyo, Japan
   Key Offering: Precision coating lines for oncology capsules, specialty film coatings, and advanced polymer blends

   FujiFilm’s acquisition of a boutique coating line has enabled it to serve high‑precision, niche therapeutic areas such as oncology.

   Sustainability & Growth Initiatives: Development of low‑solvent coatings, digital monitoring for coating quality, and partnership with research institutions.

   • Launch of low‑solvent oncology coating line
   • Collaboration with pharma on precision dosing solutions
   • Implementation of real‑time analytics for coating consistency

9. Bayer AG (Germany)

   Headquarters: Leverkusen, Germany
   Key Offering: Advanced polymers for film coating, specialty excipients for tablet and pellet applications

   Bayer’s expertise in polymer chemistry supports the development of high‑performance coatings for a broad range of therapeutic areas.

   Sustainability & Growth Initiatives: Investment in renewable polymer research, digital process controls, and reduction of solvent usage.

   • Launch of renewable polymer blend for film coating
   • Collaboration with pharma on controlled‑release formulations
   • Implementation of AI‑driven quality assurance

10. Sandoz AG (Switzerland)

    Headquarters: Holzkirchen, Switzerland
    Key Offering: Specialty excipients, polymer blends for tablet and pellet coating, and process aids

    Sandoz’s focus on generics and biosimilars drives demand for cost‑effective, high‑quality coating solutions.

    Sustainability & Growth Initiatives: Development of biodegradable additives, digital monitoring for process efficiency, and partnership with contract manufacturers.

    • Launch of biodegradable excipient line
    • Collaboration with CDMOs on generic coating solutions
    • Implementation of continuous coating technologies

Download FREE Sample Report

Get Full Report

Market Outlook to 2034

Global demand for tablet and pellet coating is expected to strengthen as the pharmaceutical sector continues to diversify its product portfolio. The shift toward complex dosage forms, coupled with an expanding pipeline of biologics and specialty drugs, will keep the market on a steady upward trajectory. Regions with rising healthcare expenditure and robust manufacturing ecosystems will drive adoption of advanced coating technologies.

Future Trends

• Continuous coating integration with end‑to‑end manufacturing lines
• Adoption of AI‑driven real‑time monitoring and predictive maintenance
• Expansion of bio‑based and renewable polymer solutions
• Growth of personalized medicine requiring flexible coating platforms
• Increased regulatory focus on sustainability and environmental impact